BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 18819004)

  • 1. Apoptotic resistance exhibited by dexamethasone-resistant murine 7TD1 cells is controlled independently of interleukin-6 triggered signaling.
    Gangavarapu KJ; Olbertz JL; Bhushan A; Lai JC; Daniels CK
    Apoptosis; 2008 Nov; 13(11):1394-400. PubMed ID: 18819004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.
    McMillin DW; Ooi M; Delmore J; Negri J; Hayden P; Mitsiades N; Jakubikova J; Maira SM; Garcia-Echeverria C; Schlossman R; Munshi NC; Richardson PG; Anderson KC; Mitsiades CS
    Cancer Res; 2009 Jul; 69(14):5835-42. PubMed ID: 19584292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triptolide overcomes dexamethasone resistance and enhanced PS-341-induced apoptosis via PI3k/Akt/NF-kappaB pathways in human multiple myeloma cells.
    Yang M; Huang J; Pan HZ; Jin J
    Int J Mol Med; 2008 Oct; 22(4):489-96. PubMed ID: 18813856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 and JAK2/STAT3 signaling mediate the reversion of dexamethasone resistance after dexamethasone withdrawal in 7TD1 multiple myeloma cells.
    Liu T; Fei Z; Gangavarapu KJ; Agbenowu S; Bhushan A; Lai JC; Daniels CK; Cao S
    Leuk Res; 2013 Oct; 37(10):1322-8. PubMed ID: 23871159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic AMP- and IL6-signaling cross talk: comodulation of proliferation and apoptosis in the 7TD1 B cell hybridoma.
    Irvin BJ; Hanson CL; Smith LH; Daniels CK
    Exp Cell Res; 2001 Apr; 265(1):73-9. PubMed ID: 11281645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PC cell-derived growth factor confers resistance to dexamethasone and promotes tumorigenesis in human multiple myeloma.
    Wang W; Hayashi J; Serrero G
    Clin Cancer Res; 2006 Jan; 12(1):49-56. PubMed ID: 16397023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the phosphatidylinositol 3-kinase pathway in multiple myeloma.
    Younes H; Leleu X; Hatjiharissi E; Moreau AS; Hideshima T; Richardson P; Anderson KC; Ghobrial IM
    Clin Cancer Res; 2007 Jul; 13(13):3771-5. PubMed ID: 17606706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of IL-6-dependent growth of myeloma cells by an acidic peptide repressing the gp130-mediated activation of Src family kinases.
    Hausherr A; Tavares R; Schäffer M; Obermeier A; Miksch C; Mitina O; Ellwart J; Hallek M; Krause G
    Oncogene; 2007 Jul; 26(34):4987-98. PubMed ID: 17310994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone protects auditory hair cells against TNFalpha-initiated apoptosis via activation of PI3K/Akt and NFkappaB signaling.
    Haake SM; Dinh CT; Chen S; Eshraghi AA; Van De Water TR
    Hear Res; 2009 Sep; 255(1-2):22-32. PubMed ID: 19442713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization of multiple myeloma and B lymphoma lines to dexamethasone and gamma-radiation-induced apoptosis by CD40 activation.
    Zhou ZH; Shi Q; Wang JF; Chen YJ; Zhuang YM; Pan JZ; Xu CS; Qi CJ; Zhang XG
    Apoptosis; 2005 Jan; 10(1):123-34. PubMed ID: 15711928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon alpha induces cell death through interference with interleukin 6 signaling and inhibition of STAT3 activity.
    Thyrell L; Arulampalam V; Hjortsberg L; Farnebo M; Grandér D; Pokrovskaja Tamm K
    Exp Cell Res; 2007 Nov; 313(19):4015-24. PubMed ID: 17880940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bortezomib, dexamethasone, and fibroblast growth factor receptor 3-specific tyrosine kinase inhibitor in t(4;14) myeloma.
    Bisping G; Wenning D; Kropff M; Gustavus D; Müller-Tidow C; Stelljes M; Munzert G; Hilberg F; Roth GJ; Stefanic M; Volpert S; Mesters RM; Berdel WE; Kienast J
    Clin Cancer Res; 2009 Jan; 15(2):520-31. PubMed ID: 19147757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 2-induced cytoplasmic asparaginyl-tRNA synthetase promotes survival of osteoblasts by regulating anti-apoptotic PI3K/Akt signaling.
    Park SJ; Kim SH; Choi HS; Rhee Y; Lim SK
    Bone; 2009 Nov; 45(5):994-1003. PubMed ID: 19631775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells.
    Lee DH; Szczepanski MJ; Lee YJ
    J Cell Biochem; 2009 Apr; 106(6):1113-22. PubMed ID: 19229860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
    Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A
    Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of PI3K/Akt partially leads to the inhibition of PrP(C)-induced drug resistance in gastric cancer cells.
    Liang J; Ge F; Guo C; Luo G; Wang X; Han G; Zhang D; Wang J; Li K; Pan Y; Yao L; Yin Z; Guo X; Wu K; Ding J; Fan D
    FEBS J; 2009 Feb; 276(3):685-94. PubMed ID: 19143835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis.
    Tang C; Lu YH; Xie JH; Wang F; Zou JN; Yang JS; Xing YY; Xi T
    Anticancer Drugs; 2009 Apr; 20(4):249-58. PubMed ID: 19174695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IL-6 receptor super-antagonist Sant7 enhances antiproliferative and apoptotic effects induced by dexamethasone and zoledronic acid on multiple myeloma cells.
    Tassone P; Galea E; Forciniti S; Tagliaferri P; Venuta S
    Int J Oncol; 2002 Oct; 21(4):867-73. PubMed ID: 12239628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen inhibits tumor cell invasion and metastasis in mouse melanoma through suppression of PKC/MEK/ERK and PKC/PI3K/Akt pathways.
    Matsuoka H; Tsubaki M; Yamazoe Y; Ogaki M; Satou T; Itoh T; Kusunoki T; Nishida S
    Exp Cell Res; 2009 Jul; 315(12):2022-32. PubMed ID: 19393235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.